drugset / Trial / NCT03013634

Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation

NCT03013634 ↗

Unknown 100 enrolled Tianjin First Central Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study was to evaluate the protective effect of dexmedetomidine on myocardial injury during liver transplantation

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Other

Indications

No indication recorded.